Guangdong Taienkang Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") held the 13th meeting of the 5th Board of Directors and the 1st extraordinary general meeting of shareholders on January 28 and February 13, 2026, respectively, to review and approve the proposal regarding the "Draft of the 2026 Employee Stock Ownership Plan of Guangdong Taienkang Pharmaceutical Co., Ltd." and its summary, among other related proposals, agreeing to implement the 2026 Employee Stock Ownership Plan. On February 13, 2026, the Company held the 14th meeting of the 5th Board of Directors, where it reviewed and approved the proposal regarding the "Revised Draft of the 2026 Employee Stock Ownership Plan of Guangdong Taienkang Ph
301263SZSE
Announcement on the Progress of the 2026 Employee Stock Ownership Plan
✨ AI Summary
This announcement details the progress of the 2026 Employee Stock Ownership Plan approved by the board and shareholders of Guangdong Taienkang Pharmaceutical Co., Ltd. on January 28 and February 13, 2026. The company has signed a trust contract with a cooperative trust institution for the plan. The board will continue to monitor the implementation and fulfill disclosure obligations as required. Investors are advised to be aware of investment risks.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.